You are here

Article Text

Article menu
Download PDFPDF
Letters
Antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis
  1. M Vargović1,
  2. M Pasini2,
  3. N Papić1,
  4. S Andrašević1,
  5. A Markotić1,3,
  6. I Butić1,
  7. V Škerk1,4
  1. 1 University Hospital for Infectious Diseases ‘Dr. Fran Mihaljević’, Zagreb, Croatia
  2. 2 University Hospital Centre Zagreb, Zagreb, Croatia
  3. 3 University School of Medicine Rijeka, Rijeka, Croatia
  4. 4 School of Dental Medicine, University of Zagreb, Zagreb, Croatia
  1. Correspondence to Professor Višnja Škerk, Clinical Department for Urinary Tract Infections, University Hospital for Infectious Diseases ‘Dr. Fran Mihaljević’, Zagreb, Croatia; vskerk{at}bfm.hr

https://doi.org/10.1136/sextrans-2013-051413

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Ureaplasma urealyticum and Mycoplasma hominis are common commensals of the lower genitourinary tract. They are causally linked to prostatitis, epydidimitis, urethral syndrome, cervicitis, urolythiasis, reactive arthritis, infertility, complications during pregnancy and serious infections in newborns and immunocompromised hosts.1 Therefore, the therapeutic use of antimicrobials and susceptibility testing is necessary because it allows adequate treatment.

    The aim of this study was to determine the susceptibility of U urealyticum and M hominis to tetracycline, erythromycin, clindamycin, doxycycline, ofloxacin and azithromycin.

    This study was conducted at the …

    View Full Text

    Footnotes

    • Funding This work was supported through the project 143-108-0002-0050, funded by The Ministry of Sciences, Education and Sports of the Republic of Croatia, and the Project 04/30 funded by The Croatian Science Foundation.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval

    • Provenance and peer review Not commissioned; internally peer reviewed.